In support of the concept that RAS/ERK signaling plays a role in inflammation, recent studies had shown that ERK1/2 phosphorylation is critical for allogeneic immune activation during graft-versus-host disease (GVHD)16 and MEK inhibition blocked these pro-inflammatory events17. This evidence concerns the gene MAP2K7 and graft versus host disease.